Hesperadin

CAS No. 422513-13-1

Hesperadin( —— )

Catalog No. M14438 CAS No. 422513-13-1

Hesperadin is a small molecule Aurora B inhibitor (IC50=250 nM) that perturbs mitosis and induces polyploidy.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 30 In Stock
5MG 47 In Stock
10MG 69 In Stock
25MG 115 In Stock
50MG 186 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Hesperadin
  • Note
    Research use only, not for human use.
  • Brief Description
    Hesperadin is a small molecule Aurora B inhibitor (IC50=250 nM) that perturbs mitosis and induces polyploidy.
  • Description
    Hesperadin is a small molecule Aurora B inhibitor (IC50=250 nM) that perturbs mitosis and induces polyploidy, causes mammalian cells to enter anaphase in the presence of monooriented chromosomes; inhibits histone H3 phosphorylation and causes midspindle defects, but does not inhibit APC and separase activation; also markedly reduces the activity of AMPK, Lck, MKK1, MAPKAP-K1, CHK1, and PHK in vitro.
  • In Vitro
    Hesperadin (10-100 nM) inhibits the Aurora kinase-1 (TbAUK1)-mediated phosphoryation of trypanosome histone H3 (TbH3) in a dose dependent manner, with an IC50 of 40 nM.Hesperadin (0.01-10 μM; 24 or 48 hours) inhibits growth of bloodstream forms (BF) and procyclic forms (PF) cultures.Hesperadin (100-200 nM; 24-72 hours) alters cell morphology and inhibits cell cycle progression similar to the RNAi knockdown of TbAUK1. Cell Viability Assay Cell Line:M110 cells Concentration:0.01, 0.1, 1, 10 μM Incubation Time:24 hours or 48 hours Result:Inhibiting growth of BF cultures with IC50 of 50 nM, while the inhibition of PF growth required approximately 11-fold more Hesperadin, with IC50 of 550 nM.Cell Cycle Analysis Cell Line:M110 cells Concentration:100, 200 nM Incubation Time:24, 48, 72 hours Result:Had a strong effect on cell growth and mitotic progression at 100-200 nM.
  • In Vivo
    Hesperadin (20 mg/kg/d; i.v.) prolongs the survival of xenograft mice via synergistic effect with temozolomide (TMZ). Animal Model:6-week-old female nude mice injected GBM cells Dosage:20 mg/kg/d Administration:I.v. injection Result:Increased the survival of xenograft mice models.
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Aurora Kinase
  • Recptor
    AuroraB(human)|TbAUK1
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    422513-13-1
  • Formula Weight
    516.6544
  • Molecular Formula
    C29H32N4O3S
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    CCS(=O)(=O)NC1=CC2=C(C=C1)NC(=C2C(=NC3=CC=C(C=C3)CN4CCCCC4)C5=CC=CC=C5)O
  • Chemical Name
    Ethanesulfonamide, N-[2,3-dihydro-2-oxo-3-[(3Z)-phenyl[[4-(1-piperidinylmethyl)phenyl]amino]methylene]-1H-indol-5-yl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hauf S, et al. J Cell Biol. 2003 Apr 28;161(2):281-94. 2. Sessa F, et al. Mol Cell. 2005 Apr 29;18(3):379-91. 3. Kapoor TM, et al. Science. 2006 Jan 20;311(5759):388-91. 4. Jetton N, et al. Mol Microbiol. 2009 Apr;72(2):442-58.
molnova catalog
related products
  • BI 831266

    BI 831266 is a potent, selective inhibitor of Aurora kinase B (AURKB) with IC50 of binding IC50 of 42 nM.

  • Hesperadin

    Hesperadin is a small molecule Aurora B inhibitor (IC50=250 nM) that perturbs mitosis and induces polyploidy.

  • TAK-901

    A multikinase inhibitor with IC50 of 21 nM and 15 nM for Aurora A/TPX2 and Aurora B/INCENP respectively; inhibits 56 kinases(IC50< 100 nM).